CME Group - CME Stock Forecast, Price & News

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View CME analyst ratings or view top-rated stocks.

15 Wall Street research analysts have issued 12 month price targets for CME Group's shares. Their CME share price forecasts range from $161.00 to $267.00. On average, they anticipate the company's stock price to reach $220.73 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $168.16 at the start of the year. Since then, CME shares have increased by 5.0% and is now trading at $176.55.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our CME earnings forecast.

CME Group will be holding an earnings conference call on Wednesday, February 8th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) posted its quarterly earnings results on Wednesday, October, 27th. The financial services provider reported $1.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.55 by $0.05. The financial services provider had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.15 billion. CME Group had a trailing twelve-month return on equity of 10.06% and a net margin of 54.01%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.38 EPS.
Read the conference call transcript.

CME Group declared a quarterly dividend on Thursday, February 2nd. Investors of record on Friday, March 10th will be paid a dividend of $1.10 per share on Monday, March 27th. This represents a $4.40 annualized dividend and a dividend yield of 2.49%. The ex-dividend date of this dividend is Thursday, March 9th. This is an increase from the stock's previous quarterly dividend of $1.00.
Read our dividend analysis for CME.

CME Group (NASDAQ:CME) pays an annual dividend of $4.00 per share and currently has a dividend yield of 2.27%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 54.42%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 48.54% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Parnassus Investments LLC (1.18%), Sarasin & Partners LLP (0.61%), Sumitomo Mitsui Trust Holdings Inc. (0.31%), AustralianSuper Pty Ltd (0.29%), Montrusco Bolton Investments Inc. (0.27%) and Troy Asset Management Ltd (0.24%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CME stock can currently be purchased for approximately $176.55.

CME Group (NASDAQ:CME) has a market capitalization of $63.51 billion and generates $4.69 billion in revenue each year. The financial services provider earns $2.64 billion in net income (profit) each year or $7.35 on an earnings per share basis.

The company employs 3,480 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for the company is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at info@cmegroup.com, or via fax at 312-466-4410.